Full Text
Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study

Abstract

Authors

D Gladman R Fleischmann K Harris L Peterson PJ Mease

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×